The IDEA program will improve participants' understanding of glucose monitoring, report interpretations, and the use of this information to optimize therapeutic management, leading to practice transformation and increased shared decision-making.

Content Contributors

Content Authors

• George Grunberger, MD, FACP, FACE, Program Co-Chairman
• Guillermo Umpierrez, MD, FACP, Program Co-Chairman
• Timothy Bailey, MD
• Richard Bergenstal, MD
• Lawrence Blonde, MD, FACE, MACE
• Jenna Brothers, PAC
• Bruce Buckingham, MD, FACE
• Ji Hyun Chun, MPAS, PA-C, BC-ADM
• Daniel Einhorn, MD, FACP, FACE
• Wendy McLaughlin, PAC
• Ann Peters, MD, CDE
• Archana R. Sadhu, MD, FACE

Planners

American Association of Clinical Endocrinologist (AACE)

• Elizabeth Lepkowski, MATD, AACE Chief Learning Officer
• Michele Lentz, AACE Chief Strategic Alliances Officer
• Beverly Hastings, AACE Live Learning Manager
• Michelle Michelotti, MHA, Director of Online Learning and Technology

American Association of Diabetes Educators (AADE)

• Nancy D’Hondt, RPh

American College of Clinical Pharmacy (ACCP)

• Daniel Aistrope, PharmD, BC-ACP
• Shelly Enders, PharmD

American Society of Endocrine Physician Assistants (ASEPA) / American Academy of Physician Assistants (AAPA)

• Ji Hyun Chun, MPAS, PA-C, BC-ADM
• Jenna Brothers, PAC
• Wendy McLaughlin, PAC

Diabetes Patient Advocacy Coalition (DPAC)

• Stewart Perry, Vic Chair, DPAC

International Diabetes Center (IDC)

• Richard Bergenstal, MD
• Gregg Simonson, PhD
• Dana Gershenoff, MS, RD, CDE

The Leona M. and Harry B. Helmsley Charitable Trust

• David Panzier

T1D Exchange

• Alicia McAuliffe-Fogarty

The diaTribe Foundation

• Ms. Kelly Close

The France Foundation

• Theodore Bruno, MD
• Ailene Cantelmi
• Amanda Noe
• Heather Tarbox, MPH
• Eve Wilson, PhD

1. Discuss the limitations of A1c as a marker of diabetes control

2. Explain the merits of evaluating time in range and hypoglycemic and hyperglycemic excursions and as well as A1c

3. Describe how glucose monitoring devices facilitate prevention, detection, and prompt treatment of hypoglycemia

4. Discuss improved patient outcomes associated with glucose monitoring as well as technological advances that have improved the ease of use of these devices

• Endocrinologists
• Primary care clinicians, including Physician Assistants and Nurse Practitioners
• Diabetes Educators (including CDE, RN, PharmD)
• Patients and Caregivers living with Diabetes